Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203683 · ClinicalTrials.gov registry record · Phase 3
Testing the Effectiveness of a Computer-based Program for Depression
A Phase 3 study of Major Depressive Disorder, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 3
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT01203683 is a Phase 3 study of Major Depressive Disorder that has completed, run by University of Texas at Austin. The registered enrollment target is 53 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01203683, a Phase 3 study of Major Depressive Disorder, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether completing a computer-based program alters changes how the brain processes emotional information and improves symptoms of depression.
Conditions Studied
Interventions
- BEHAVIORAL Active computer-based training
- BEHAVIORAL Inert computer training
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01203683
The ClinicalTrials.gov registry entry for NCT01203683 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (86% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active computer-based training is the first listed.
NCT01203683 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01203683 about?
NCT01203683 is a clinical study titled "Testing the Effectiveness of a Computer-based Program for Depression". The purpose of this study is to determine whether completing a computer-based program alters changes how the brain processes emotional information and improves symptoms of depression.
What is the current status of trial NCT01203683?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 53 participants. The study started on 2011-01. Estimated completion is 2013-10.
What conditions does trial NCT01203683 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT01203683?
The interventions under investigation include: Active computer-based training (BEHAVIORAL), Inert computer training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01203683?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01203683 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 3
-
Study to Assess the Safety and Effectiveness of NMRA-335140-501
RECRUITING · Phase 3
-
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 3
-
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
RECRUITING · Phase 3
-
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
RECRUITING · Phase 3
-
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.